  See all
 | Articles: Neuro/Psych Pharmacol |
The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia
Current Opinion in Psychiatry, 10/30/08
 | | Sponsor |
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimers disease
Advanced Drug Delivery Reviews, 10/27/08
Use of benzodiazepines, depressive symptoms and cognitive function in old age
International Journal of Geriatric Psychiatry, 10/24/08
Psychiatric Polypharmacy: Identifying Risks and Seeking Solutions
Joint Commission Perspectives on Patient Safety, 10/24/08
Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD: Final Report of a 4-Year Study
Journal of Attention Disorders, 10/23/08
Clozapine, Olanzapine, or Typical Antipsychotics for Alcohol Use Disorder in Patients With Schizophrenia
Journal of Dual Diagnosis, 10/21/08
Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Clinical Neuropharmacology, 10/21/08
Carbamazepine-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in a 35-Year-Old Man With Epilepsy
Clinical Neuropharmacology, 10/21/08
Does a History of Alcohol Use Disorder Affect Response to Antidepressant Medication in Patients With Dysthymic Disorder
Journal of Dual Diagnosis, 10/21/08
Open-Label Study of Craving in Smokers With Schizophrenia Using Nicotine Nasal Spray Compared to Nicotine Patch
Journal of Dual Diagnosis, 10/21/08
|
|
Receive daily email updates on Neuro/Psych Pharmacol
|
|
Indexed Journals: Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
Read a Different Specialty |
|
|
|
|
|
Psychiatric News Profession Index
|
|
|
|
|
|
|
 |
| Sponsor |
|
